- Home
- KRKR vs APTO Comparison
KRKR vs APTO Comparison
Compare KRKR & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- APTO
- Stock Information
- Founded
- KRKR 2010
- APTO 1986
- Country
- KRKR China
- APTO Canada
- Employees
- KRKR N/A
- APTO N/A
- Industry
- KRKR Business Services
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRKR Consumer Discretionary
- APTO Health Care
- Exchange
- KRKR Nasdaq
- APTO Nasdaq
- Market Cap
- KRKR 7.6M
- APTO 7.4M
- IPO Year
- KRKR 2019
- APTO N/A
- Fundamental
- Price
- KRKR $3.10
- APTO $0.19
- Analyst Decision
- KRKR
- APTO Strong Buy
- Analyst Count
- KRKR 0
- APTO 3
- Target Price
- KRKR N/A
- APTO $4.33
- AVG Volume (30 Days)
- KRKR 6.5K
- APTO 700.2K
- Earning Date
- KRKR 12-05-2024
- APTO 11-08-2024
- Dividend Yield
- KRKR N/A
- APTO N/A
- EPS Growth
- KRKR N/A
- APTO N/A
- EPS
- KRKR N/A
- APTO N/A
- Revenue
- KRKR $41,654,350.00
- APTO N/A
- Revenue This Year
- KRKR $45.99
- APTO N/A
- Revenue Next Year
- KRKR $31.46
- APTO N/A
- P/E Ratio
- KRKR N/A
- APTO N/A
- Revenue Growth
- KRKR N/A
- APTO N/A
- 52 Week Low
- KRKR $3.03
- APTO $0.13
- 52 Week High
- KRKR $14.88
- APTO $2.91
- Technical
- Relative Strength Index (RSI)
- KRKR 30.80
- APTO 21.08
- Support Level
- KRKR $3.03
- APTO $0.35
- Resistance Level
- KRKR $3.71
- APTO $0.41
- Average True Range (ATR)
- KRKR 0.27
- APTO 0.03
- MACD
- KRKR -0.07
- APTO -0.02
- Stochastic Oscillator
- KRKR 5.37
- APTO 20.69
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.